CARLSBAD, Calif., Feb. 16, 2011 /PRNewswire/ -- Patriot Scientific Corporation (BULLETIN BOARD: PTSC) , today announced the latest in a remarkable string of successes in defeating the nearly four-year-old serial attack on the MMP Portfolio. The United States Patent and Trademark Office (USPTO) has issued a Reexamination Certificate for the US'890 patent, and a Notice of Intent to Issue Reexamination Certificate for the US'749 patent.
The conclusion of the US'749 reexam is actually a victory over three merged reexamination challenges filed by ARM, Fish & Richardson, and HTC, in which the USPTO was asked to consider over 800 prior art references. Likewise, there were over 600 prior art references before the USPTO when it sustained the US'890.
These new successes extend a string of reexamination victories for the MMP patents, which include:
-- NOV 2010 - The USPTO denied a Reexamination Request for US'336 anonymously filed by Chen Yoshimura LLP, ending the sixth reexamination request on US'336. -- NOV 2010 - The USPTO issued a Reexamination Certificate for US'336 anonymously filed by Fish and Richardson, ending the fourth reexamination request on US'336. -- DEC 2009 - The USPTO issued a Reexamination Certificate for US'336 filed by NEC, Toshiba, and the Public Patent Foundation, ending the first, second and third reexaminations on US'336. -- JUL 2009 - The USPTO denied a Reexamination Request for US'336 filed by HTC, ending the fifth reexamination request on US'336. -- JUL 2009 - The USPTO issued a Reexamination Certificate for US'584 "Multiple Instruction Fetch" over the reexaminations filed by litigants NEC and Toshiba. -- JAN 2009 - The German Patent Court confirms the validity of EP '730 rejecting a "nullity action" brought by Deutsch Telecom.
Of the sixteen reexamination attacks to date on MMP Portfolio patents, twelve have been concluded successfully in favor of the MMP Portfolio, and four matters remain ongoing.
Earlier this month, MMP Portfolio co-owners The TPL Group and Patriot Scientific announced a substantial increase in working capital to the MMP Portfolio licensing and litigation programs in response to the growing confidence in the fundamental patent portfolio.
"We have eagerly awaited the successful validation of the MMP Portfolio through the reexamination process, and appreciate the fine work of the Alliacense team," stated Carlton Johnson, chairman of the executive committee of Patriot's Board of Directors.
"This remarkable string of victories exponentially increases the risks to those users of the technology who have not yet chosen to join the ranks of the over 80 MMP Portfolio Licensees around the world," according to Dan Leckrone, Chairman of The TPL Group which is likewise a co-owner of the MMP Portfolio, adding that "As Congress again considers potential changes to the US patent system, abuses of the System by serial infringers ought to be near the top of the agenda."
About Patriot Scientific
Headquartered in Carlsbad, California, Patriot Scientific Corporation provides data sharing and secure data solutions for a connected world. Patriot Scientific addresses the expanding market opportunities in the justice and public safety industries through its wholly owned subsidiary Patriot Data Solutions Group, Inc. These growth activities are funded with revenues generated, in a large part, from the Moore Microprocessor Patent(TM) Portfolio licensing partnership with The TPL Group. Patriot Scientific's integrated core intelligence solution addresses the critical data/information sharing needs of the healthcare industry, the Department of Homeland Security, the Department of Justice, and federal, state, and local public safety and law enforcement agencies. For more information on Patriot Scientific Corporation, visit: http://www.ptsc.com/.
About Alliacense
Alliacense is a recognized leader in the design and execution of Intellectual Property (IP) licensing programs. As a cadre of IP licensing strategists, technology experts, and experienced business development/management executives, Alliacense focuses on expanding the awareness and value of IP portfolios under management. For more information, visit http://www.alliacense.com/.
About The TPL Group
Founded in 1988, Technology Properties Limited (The TPL Group) has emerged as a global coalition of high technology enterprises involved in the development, management and commercialization of Intellectual Property (IP) assets as well as the design, manufacture and sales of proprietary products based on these same IP assets. Among the advanced products that The TPL Group enterprises continue to develop and bring to market are multicore microprocessors as well as other system-on-chip solutions for distributed digital media processing applications. For more information, visit http://www.tplgroup.net/.
About the MMP Portfolio(TM)
The MMP Portfolio patents, filed by The TPL Group in the 1980s, include seven US patents as well as their European and Japanese counterparts, cover techniques that enable higher performance and lower cost designs essential to consumer and commercial digital systems ranging from PCs, cell phones and portable music players to communications infrastructure, medical equipment and automobiles. The MMP Portfolio patents were co-invented by Charles H. Moore who is known for various contributions to computer chip and micro-processor technologies and design tools.
The MMP Portfolio(TM) is widely recognized as fundamental technology. The sweeping scope of applications using MMP Portfolio design techniques continues to encourage the world's leading manufacturers of end-user products from around the globe to become MMP Portfolio licensees. Over 80 global companies from the US, Europe, Japan, Korea and Taiwan have licensed the MMP Portfolio(TM) technologies. Manufacturers can learn more about how to participate in the MMP Portfolio(TM) Licensing Program by contacting: mmp-licensing@alliacense.com.
Statements in this press release which are not purely historical, including statements regarding Patriot Scientific Corporation's intentions, hopes, beliefs, expectations, representations, projections, plans or predictions of the future are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The forward-looking statements involve risks and uncertainties including the risk factors listed from time to time in the company's SEC reports including, but not limited to, the annual report on Form 10-K for the year ended May 31, 2010. The company cautions investors not to place undue reliance on the forward-looking statements contained in this press release. Patriot Scientific Corporation disclaims any obligation, and does not undertake to update or revise any forward-looking statements in this press release.
Contact: Patriot Investor Relations ir@ptsc.com 760-547-2700
Patriot Scientific Corporation
CONTACT: Patriot Investor Relations, +1-760-547-2700, ir@ptsc.com
Web Site: http://www.ptsc.com/
http://www.alliacense.com/
http://www.tplgroup.net/
